|  | suspLN | N statusa | ||||
---|---|---|---|---|---|---|---|
n = 137 | yes | no | p-value | N0 | N+ | p-value | |
Tumor sizeb | |||||||
  ≥ 5 cm | 99 (72.3%) | 38 (27.7%) | 61 (44.5%) | 0.105 | 63 (52.1%) | 26 (21.5%) | 0.236 |
  < 5 cm | 38 (27.7%) | 9 (6.6%) | 29 (21.2%) |  | 19 (15.7%) | 13 (10.7%) |  |
Multifocal disease | |||||||
 No – solitary | 96 (70.1%) | 30 (21.9%) | 66 (48.2%) | 0.249 | 56 (46.3) | 26 (21.5%) | 0.858 |
 Yes | 41 (29.9%) | 17 (12.4%) | 24 (17.5%) |  | 26 (21.5%) | 13 (10.7%) |  |
Number of nodules | |||||||
  ≤ 2 | 105 (76.6%) | 32 (23.4%) | 73 (53.3%) | 0.087 | 64 (52.9%) | 27 (22.3%) | 0.294 |
  ≥ 3 | 32 (23.4%) | 15 (10.9%) | 17 (12.4%) |  | 18 (14.9%) | 12 (9.9%) |  |
T status | |||||||
 T1 + 2 | 103 (75.2%) | 32 (23.4%) | 71 (51.8%) | 0.165 | 69 (57%) | 20 (16.5%) | < 0.001 |
 T3 + 4 | 34 (24.8%) | 15 (10.9%) | 19 (13.9%) |  | 13 (10.8%) | 19 (15.7%) |  |
UICC stagea | |||||||
 UICC I + II | 67 (55.4%) | 10 (8.3%) | 57 (47.1%) | < 0.001 | 67 (55.4%) | – | < 0.001 |
 UICC III + IV | 54 (44.6%) | 35 (28.9%) | 19 (15.7%) |  | 15 (12.4%) | 39 (32.2%) |  |